About this episode

This episode focuses on improving the diagnosis and management of obstructive hypertrophic cardiomyopathy (oHCM).

Chair: Iacopo Olivotto Faculty: Elena Arbelo Faculty: Silvia Aguiar Did you miss our symposium at ESC HF 2026? It’s not too late! This CME-accredited broadcast replay focuses on improving the diagnosis and management of obstructive hypertrophic cardiomyopathy (oHCM). Learn how to distinguish oHCM from heart failure and how cardiac myosin inhibitors can optimize patient outcomes. Join us and gain valuable tips on applying these insights in practice. For more information please visit the Heart Failure Congress 2026 website .

More episodes of CME

• No Patient With CKD Left Behind: New Horizons in Patients With CKD Regardless of Diabetes Status · July 14, 2026 · 13 min
• Closing the Gaps: Global Implementation of Lipid Guidelines · June 30, 2026 · 1h 0m
• Translating Evidence Into Action: Nonsteroidal MRAs in Patients With HF · June 23, 2026 · 17 min
• Chairperson’s Perspective: Reframing First-Line and Subsequent Care in Advanced Urothelial Carcinoma – Clinical Implications of the Updated NCCN Guidelines · June 1, 2026 · 14 min
• Chairperson’s Perspective: HER2 in Solid Tumors – From Pathology to Personalized Treatment Plans · June 1, 2026 · 18 min
• Before the Scalpel: Identifying Candidates for Perioperative Immunotherapy · May 29, 2026 · 5 min

Explore listener stats, chart rankings, contacts and more on the CME podcast page.